| Theme |
The Current State of Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas |
| Title |
Concomitant Malignancies in Extrapancreatic Organs with IPMN |
| Author |
Takashi Hatori |
Department of Gastroenterological Surgery, Tokyo Womenʼs Medical University |
| Author |
Manami Doi |
Department of Gastroenterological Surgery, Tokyo Womenʼs Medical University |
| Author |
Nana Ooshima |
Department of Gastroenterological Surgery, Tokyo Womenʼs Medical University |
| Author |
Akira Kimijima |
Department of Gastroenterological Surgery, Tokyo Womenʼs Medical University |
| Author |
Toru Furukawa |
Department of Institute for Integrated Medical Sciences, Tokyo Womenʼs Medical University |
| Author |
Yukiko Takayama |
Department of Gastroenterology, Tokyo Womenʼs Medical University |
| Author |
Kyoko Shimizu |
Department of Gastroenterology, Tokyo Womenʼs Medical University |
| Author |
Keiko Shiratori |
Department of Gastroenterology, Tokyo Womenʼs Medical University |
| Author |
Masakazu Yamamoto |
Department of Gastroenterological Surgery, Tokyo Womenʼs Medical University |
| [ Summary ] |
Malignant diseases of extrapancreatic organs that occur in 20-30 % of patients with intraductal papillary mucinous neoplasms (IPMN) can be either synchronous or metachronous. The frequency and location of extrapancreatic malignancies differ from country to country. The relationship between IPMN types and extrapancreatic malignancies is controversial, although the latter sometimes affects the prognosis of patients with IPMN, particularly in those with benign or non-invasive IPMN. Implementing a screening system for early diagnosis and treatment of extrapancreatic malignancies may help to achieve better prognosis in patients with IPMN. |